An inhibitor of MAGL (IC50 = 9.1 nM) and to a lesser extent ABHD6 with potent selectivity over FAAH (IC50 > 10 µM) and other brain serine hydrolases; inhibits 2-AG hydrolysis (IC50 = 2.1 nM) with no effect on AEA hydrolysis up to 50 µM; alleviates mechanical allodynia in a rat model of diabetic neuropathy at 5 mg/kg.